Alkylated cyclodextrin compositions and processes for preparing and using the same
AssigneeCyDex Pharmaceuticals, Inc.
InventorsVincent D. Antle, Alvaro Lopes, Daniel Monteiro
Life of this patent
Estimating the term…
Abstract
The present invention related to low-chloride alkylated cyclodextrin compositions, along with processes for preparing and using the same. The processes of the present invention provide alkylated cyclodextrins with low levels of drug-degrading agents and chloride.
Claims64
A process for preparing an alkylated cyclodextrin composition comprising an alkylated cyclodextrin, the process comprising:
- (a) mixing a cyclodextrin with an alkylating agent to form a reaction milieu comprising an alkylated cyclodextrin, one or more unwanted components, and one or more drug-degrading impurities;
- (b) conducting one or more separations to remove the one or more unwanted components from the reaction milieu to form a partially purified solution comprising the alkylated cyclodextrin and the one or more drug-degrading impurities, wherein the one or more separations are ultrafiltration, diafiltration, centrifugation, extraction, solvent precipitation, or dialysis;
- and
- (c) treating the partially purified solution with a phosphate-free activated carbon having a residual conductivity of 10 μS or less and producing the alkylated cyclodextrin.
An alkylated cyclodextrin composition, comprising:
- an alkylated cyclodextrin having an average degree of substitution of 2 to 9;
- less than 500 ppm of a phosphate;
- and
- 0.07% (w/w) or less of a chloride;
- wherein the alkylated cyclodextrin composition has an absorption of less than 1 A.U., as determined by UV/vis spectrophotometry at a wavelength of 245 nm to 270 nm for an aqueous solution containing 300 mg of the alkylated cyclodextrin composition per mL of solution in a cell having a 1 cm path length.
An alkylated cyclodextrin composition comprising:
- an alkylated cyclodextrin having an average degree of substitution of 2 to 9;
- less than 500 ppm of a phosphate;
- and
- 0.07% (w/w) or less of a chloride;
- wherein the alkylated cyclodextrin composition has an absorption of 0.5 A.U. or less as determined by UV/vis spectrophotometry at a wavelength of 245 nm to 270 nm for an aqueous solution containing 500 mg of the alkylated cyclodextrin composition per mL of solution in a cell having a 1 cm path length.
An alkylated cyclodextrin composition, comprising:
- an alkylated cyclodextrin having an average degree of substitution of 2 to 9;
- less than 500 ppm of a phosphate;
- and
- 0.07% (w/w) or less of a chloride;
- wherein the alkylated cyclodextrin composition has an absorption of less than 1 A.U., as determined by UV/vis spectrophotometry at a wavelength of 320 nm to 350 nm for an aqueous solution containing 300 mg of the alkylated cyclodextrin composition per mL of solution in a cell having a 1 cm path length.
An alkylated cyclodextrin composition comprising:
- an alkylated cyclodextrin having an average degree of substitution of 2 to 9;
- less than 500 ppm of a phosphate;
- and
- 0.07% (w/w) or less of a chloride;
- wherein the alkylated cyclodextrin composition has an absorption of 0.5 A.U. or less as determined by UV/vis spectrophotometry at a wavelength of 320 nm to 350 nm for an aqueous solution containing 500 mg of the alkylated cyclodextrin composition per mL of solution in a cell having a 1 cm path length.
Dependencies are inferred from the claim text.